Publications

What if metabolic syndrome isn't really about blood sugar and belly fat – but a total communication breakdown inside your cells? 🧬

European Wellness researchers have just published a compelling new review in Neurology – Research & Surgery – exploring how metabolic syndrome may actually be a systems-wide collapse of peptide signaling across your organs, and how regenerative peptide biology could offer a new way to address it at the source!

Here's the big picture:

• The paper reframes Metabolic Syndrome as a coordinated collapse of peptide-governed networks connecting the gut, pancreas, liver, muscles, fat tissue, and mitochondria.
• When these communication lines break down, things such as insulin sensitivity, inflammation, and cellular energy production start falling out of sync.
• This review explores how next-gen peptide therapeutics may help reconnect the network, including Mitochondrial Peptides, Nano Organo-Peptides, Klotho Peptides, Organ-Specific Peptides, and Mito Organelles.

Metabolic syndrome affects nearly 1 in 4 adults worldwide – and conventional treatments often manage symptoms without addressing the deeper biological failures driving the condition.

This review positions regenerative peptide therapeutics as a coherent, systems-level strategy capable of restoring the upstream peptide networks that keep our metabolism balanced, resilient, and healthy.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

Peptides 101: Regenerative Applications in Modern Medicine provides a foundational overview of peptide biology and their expanding therapeutic roles in regenerative and functional medicine. The book reviews peptide structure, synthesis, and signaling pathways, with emphasis on their applications in tissue repair, immune modulation, neuroprotection, and metabolic regulation. Integrating current research with clinical perspectives, it highlights safety profiles, evidence-based protocols, and emerging trends in peptide therapeutics. Designed for clinicians, biomedical researchers, and students, this text bridges basic science and translational medicine to illuminate the regenerative potential of peptide-based interventions.

Unlock the therapeutic power of peptides—nature’s own precision messengers—in this comprehensive introduction to their role in regenerative and integrative medicine. From cellular signaling and tissue repair to neuroprotection and metabolic optimization, Peptides 101 demystifies complex biochemical pathways and translates cutting-edge science into practical medical insight.

Inside, you’ll explore:

• Core principles of peptide biology and receptor signaling; Clinical applications in reversal of chronic diseases and metabolic syndrome, wound healing, longevity and neuroregeneration;
• Evidence-based discussion of safety, dosing, and protocols;
• Future directions in peptide-based therapeutics and personalized medicine.
• Whether you’re a physician, researcher, or student of modern bioregenerative science, this book provides the foundation and framework to understand and apply peptide therapy responsibly and effectively.

Prof. Dato’ Sri Dr. Mike K.S. Chan, Researcher, Author, and Educator, Founder and Chairman of the European Wellness Biomedical Group; Senior Technical Consultant at EWBG; Head of Scientific committee of preventive, regenerative and anti-aging medicine and Asian Chairman (ESAAM); Adjunct Professor of Lincoln University College (Malaysia); Associate Professor of AASCP, USA (American Academy of Stem Cell Physicians), Chairman for A4M, USA (American Academy of Anti-Aging Medicine) for Thailand/Asia, Japan’s Regenerative Medical Association MMJ (Multi-Dimensional Holistic Medical Team Japan) and co-Founder of FCTI Precursor Stem Cells (Europe), Author of over 70 books and over 150 publications, has experience of 45 over years in Stem cells Research in Germany, Switzerland, European Union, Soviets, China, Mexico, USA, Japan, Middle East since early 80’s, presenter for over 10000 presentations and scientific lectures globally at most major conferences of the World on anti-aging and precision medicine. He is also a pioneer in Regenerative Medicine and Cellular Therapies in a big way in the 80’s into Asia Pacific, the Middle East and Australia.

Thomas Skutella, MD, PostDoc (Max Planck Institute for Psychiatry, Munich, Germany), Full Professor at Heidelberg University, former group leader in the Neuroscience Research Center (Charite Berlin, Germany), director of the Center for Regenerative Medicine (Tübingen, Germany), Head of the department of Neuroanatomy in the Institute for Anatomy and Cell Biology (Heidelberg, Germany), Group for Regeneration and Reprogramming, Medical Faculty, Institute for Anatomy and Cell Biology, Heidelberg University (Germany).

Jonathan R.T. Lakey, B.Sc., M.Sc., Ph.D. (University of Alberta at Edmonton, Canada), Professor Emeritus, Department of Surgery, University of California Irvine (CA, USA); Department of Biomedical Engineering, University of California Irvine (CA, USA), Director of Research at the Clinical Islet Program in the Department of Surgery at the University of California, Irvine (CA, USA), Outstanding Leadership in Alberta Science Award from the Alberta Science and Technology Leadership Foundation, the Outstanding Achievement Award from the Canadian Diabetes Association, and Royal College of Physicians and Surgeons.

Olha Nishkumai, MD, PhD, Professor, Doctor of Medical Sciences, Board Certified Specialist Cardiologist, Rheumatologist, and Internal Medicine specialist; Full Professor at the Department of Internal Medicine No. 2 at Bogomolets National Medical University (UA); Medical Consultant at the European Wellness Biomedical Group.

Dmytro Klokol, MD, Specialist in General Surgery (Board Certified, MoH UA), PhD (Emergency and Reconstructive Surgery), GCP (Malaysia, USA), PostDoc (Regenerative Medicine, NL, EU); Certified expert in Interventional procedures in Regenerative Medicine and chronic pain management (Spain, EU); Certified Educator at International Accreditation Organization (IAO, USA); HRDCorp certified educator and trainer (Malaysia); International Board for Anti-aging and Regenerative Medicine (IBARM, USA) certifying academic board member.

Here's What It's About:

This case report follows a 27-year-old patient with severe corneal opacity treated over 90 days using ACE Retino (sublingual and topical peptides) and Cataclear (bioactive eye drops).

Key observations include:

• 92% improvement in corneal clarity
• Significant visual acuity gains
• Reduced stromal edema
• And marked improvements in inflammatory and oxidative biomarkers – all without surgical intervention.

💡 Why This Matters:

Corneal opacity affects millions globally and often requires surgery with associated risks. This preliminary case suggests peptide-based therapies targeting inflammation, oxidative stress, and fibrosis may offer a promising non-invasive alternative – though larger controlled trials are needed.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

European Wellness researchers and collaborators have just published a comprehensive review in the Journal of Neurological Sciences and Research – exploring how tinnitus is now understood as a complex brain network disorder, and how peptide-based regenerative therapies may offer a promising new path forward!

Here's the breakthrough:

Tinnitus affects 10 – 15% of adults globally – yet current treatments only manage symptoms. This paper digs into the real culprits:

✅ Cochlear injury sparking maladaptive brain rewiring

✅ Oxidative stress, mitochondrial dysfunction, and neuroinflammation keeping the "phantom sound" alive

✅ Limbic–auditory network disruptions fueling emotional distress

The potential solution?

Peptide-based biologics – including Mito-Organelles (MO), Nano Organo-Peptides (NOP), and Precursor Stem Cell–derived factors – that can:

✅ Restore cellular energy and calm hyperactive neurons

✅ Rebalance brain circuits and reduce aberrant neural "noise"

✅ Support neuro-regeneration at the source

MORE PUBLICATIONS:
https://european-wellness.eu/publications/

About the Article:

Reproductive health is critical to the welfare, performance, and sustainability of animal populations, from companion animals to livestock and equines. Traditional reproductive management strategies often focus on hormonal modulation or assisted reproductive technologies, which can improve breeding efficiency but may not address the underlying cellular, endocrine, and metabolic dysfunctions that contribute to infertility and sub‑fertility in animals.

This comprehensive review synthesizes the latest evidence on peptide‑based therapies and organ‑derived biologics as next‑generation tools in animal reproductive care. Peptide therapeutics, whether synthetic, stem‑cell secretome‑derived, or organ extract‑based offer targeted modulation of:

• Endocrine balance and steroidogenesis
• Mitochondrial bioenergetics and oxidative homeostasis
• Angiogenesis and tissue repair by modulating key reproductive and regenerative pathways

MORE PUBLICATIONS:
https://european-wellness.eu/publications/